I agree that this site is using cookies. You can find further informations here.
X
Zolotukhin, Irene
44  results:
Search for persons X
?
1

Effect of CpG Depletion of Vector Genome on CD8+ T Cell Res..:

Bertolini, Thais B. ; Shirley, Jamie L. ; Zolotukhin, Irene...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
2

Engineering and In Vitro Selection of a Novel AAV3B Variant..:

Biswas, Moanaro ; Marsic, Damien ; Li, Ning...
Molecular Therapy - Methods & Clinical Development.  19 (2020)  - p. 347-361 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Type I IFN Sensing by cDCs and CD4+ T Cell Help Are Both Re..:

Shirley, Jamie L. ; Keeler, Geoffrey D. ; Sherman, Alexandra...
Molecular Therapy.  28 (2020)  3 - p. 758-770 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Biodistribution of adeno-associated virus type 2 with mutat..:

Gorbatyuk, Oleg S. ; Warrington JR., Kenneth H. ; Gorbatyuk, Marina S....
Virus Research.  274 (2019)  - p. 197771 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Evaluation of engineered AAV capsids for hepatic factor IX ..:

Markusic, David M. ; Nichols, Timothy C. ; Merricks, Elizabeth P....
Journal of Translational Medicine.  15 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
6

Potential for cellular stress response to hepatic factor VI..:

Zolotukhin, Irene ; Markusic, David M ; Palaschak, Brett...
Molecular Therapy - Methods & Clinical Development.  3 (2016)  - p. 16063 , 2016
Link: https://doi.org/10.1038/..
 
?
7

688. Supplemental Immune Suppression Is Required for AAV-F8..:

Markusic, David ; Palaschak, Brett ; Zolotukhin, Irene.
Molecular Therapy.  24 (2016)  - p. S272-S273 , 2016
Link: https://doi.org/10.1016/..
 
?
8

Superior In vivo Transduction of Human Hepatocytes Using En..:

Vercauteren, Koen ; Hoffman, Brad E ; Zolotukhin, Irene...
Molecular Therapy.  24 (2016)  6 - p. 1042-1049 , 2016
Link: https://doi.org/10.1038/..
 
?
9

Dynamics of antigen presentation to transgene product-speci..:

Perrin, George Q ; Zolotukhin, Irene ; Sherman, Alexandra...
Molecular Therapy - Methods & Clinical Development.  3 (2016)  - p. 16083 , 2016
Link: https://doi.org/10.1038/..
 
?
10

40. Transgene Product-Specific Treg Are Initially Induced i..:

Perrin, George Q. ; Zolotukhin, Irene ; Herzog, Roland W.
Molecular Therapy.  23 (2015)  - p. S18 , 2015
Link: https://doi.org/10.1016/..
 
?
11

519. Unique Role of the TLR9-MyD88 Signaling Pathway in Den..:

Rogers, Geoffrey L. ; Zolotukhin, Irene ; Herzog, Roland W.
Molecular Therapy.  23 (2015)  - p. S208 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Prevalence of neutralizing antibodies against liver-tropic ..:

Ling, Chen ; Wang, Yuan ; Feng, Ying-lu...
Journal of Integrative Medicine.  13 (2015)  5 - p. 341-346 , 2015
Link: https://doi.org/10.1016/..
 
?
13

Unique Roles of TLR9- and MyD88-Dependent and -Independent ..:

Rogers, Geoffrey L. ; Suzuki, Masataka ; Zolotukhin, Irene...
Journal of Innate Immunity.  7 (2015)  3 - p. 302-314 , 2015
Link: https://doi.org/10.1159/..
 
?
14

Role of the vector genome and underlying factor IX mutation..:

Rogers, Geoffrey L ; Martino, Ashley T ; Zolotukhin, Irene..
Journal of Translational Medicine.  12 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
15

Immune Tolerance Induction to Factor IX through B Cell Gene..:

Wang, Xiaomei ; Moghimi, Babak ; Zolotukhin, Irene...
Molecular Therapy.  22 (2014)  6 - p. 1139-1150 , 2014
Link: https://doi.org/10.1038/..
 
1-15